Zhejiang Shengda Bio-Pharm Co., Ltd. (603079.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 3.15B |
| Enterprise Value | 3.11B |
| P/E Ratio | 43.93 |
| PEG Ratio | -3,956.63T |
| Price/Sales Ratio | 2.92 |
| Price/Book Ratio | 1.51 |
| Enterprise/Revenue | 2.63 |
| Enterprise/EBITDA | 24.37 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.06 |
| Operating Margin | 0.08 |
AD
Management Effectiveness
| Return On Assets | 0.02 |
| Return On Equity | 0.03 |
Income Statement
| Revenue | 844.54M |
| Revenue/Share | 4.41 |
| Gross Profit | 220.87M |
| EBITDA | 158.44M |
| Net Income | 62.16M |
| Diluted EPS | 0.35 |
Balance Sheet
| Total Cash | 603.14M |
| Total Cash/Share | 3.2 |
| Total Debt | 330.71M |
| Total Debt/Equity | 0.21 |
| Current Ratio | 4.69 |
| Book Value Per Share | 8.66 |
Price History
| 52-Week Change | -26.21 |
| 52-Week High | 22 |
| 52-Week Low | 11.91 |
| Moving Average 50 Days | 15.01 |
| Moving Average 200 Days | 17.54 |
Statistics
| Average Volume | 3.06M |
| Shares Outstanding | 189.03M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0.11 |
| Last Split Factor | 7:5 |
| Last Split Date | June 08, 2020 |
AD
